RWE 101 – 4 Potential Uses for Improving Drug Development
Real world data (RWD) refers to any data that is generated outside of a clinical trial setting, such as data collected from electronic health records (EHRs), claims data, and data from wearables and mobile devices. Real world evidence (RWE), on the other hand, is the evidence that is derived from the analysis of RWD, and is used to inform decisions about healthcare interventions.
In other words, RWE is the result of the analysis of RWD in order to generate evidence that can be used to support decision-making in healthcare. RWE is increasingly being used to complement traditional clinical trial data, as it allows for a broader understanding of the effectiveness and safety of treatments in real-world settings, beyond the controlled environment of clinical trials.
For example, RWE can be used to assess the effectiveness of a new drug in a real-world population, by analyzing the outcomes of patients who have received the drug outside of a clinical trial. This can provide valuable insights into the drug’s real-world performance, and help inform clinical practice and regulatory decisions.
Overall, the connection between real-world data and real-world evidence is that RWE is the result of the analysis of RWD, and is used to generate evidence that can be used to inform decisions about healthcare interventions.
Share this story...
Real World Evidence (RWE) 101 – Registry vs Registry-Based Study
RWE 101 - Registry vs Registry-Based Study In the context of real-world evidence, a registry is a collection of data on a particular disease, medical condition, or [...]
Real World Evidence (RWE) 101 – Pregnancy Registries
RWE 101 - Pregnancy Registries A pregnancy registry is a type of real-world evidence collection system that collects data from pregnant women who have been exposed to [...]
Real World Evidence (RWE) 101 – Diversity
RWE 101 - Diversity Diversity in the context of real-world research refers to the inclusion of individuals from different backgrounds, including but not limited to race, ethnicity, gender, [...]
Real World Evidence (RWE) 101 – The Patient Voice
RWE 101 - The Patient Voice The patient voice refers to the perspectives, opinions, and experiences of patients and their families or caregivers in the context of [...]
Real World Evidence (RWE) 101 – ISPE GPP
RWE 101 - ISPE GPP The International Society of Pharmacoepidemiology (ISPE) Good Pharmacoepidemiology Practices (GPP) provides guidance for the conduct and reporting of pharmacoepidemiologic studies. The key [...]
Real World Evidence (RWE) 101 – EMA Good Pharmacovigilance Practices (GVPs)
RWE 101 - EMA Good Pharmacovigilance Practices (GVPs) The European Medicines Agency's (EMA) Good Pharmacovigilance Practices (GVPs) provide a framework for the monitoring and reporting of adverse drug [...]
